Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 2003; 96(Suppl 43): 30–34.
PMCID: PMC1308785

Asthma in cystic fibrosis.

Full Text

The Full Text of this article is available as a PDF (80K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA. Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol. 1999 Oct;28(4):248–254. [PubMed]
  • Balfour-Lynn IM, Elborn JS. "CF asthma": what is it and what do we do about it? Thorax. 2002 Aug;57(8):742–748. [PMC free article] [PubMed]
  • Koch C, McKenzie SG, Kaplowitz H, Hodson ME, Harms HK, Navarro J, Mastella G. International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF). Pediatr Pulmonol. 1997 Aug;24(2):147–161. [PubMed]
  • Cooper PJ, Robertson CF, Hudson IL, Phelan PD. Variability of pulmonary function tests in cystic fibrosis. Pediatr Pulmonol. 1990;8(1):16–22. [PubMed]
  • Warner JO, Götz M, Landau LI, Levison H, Milner AD, Pedersen S, Silverman M. Management of asthma: a consensus statement. Arch Dis Child. 1989 Jul;64(7):1065–1079. [PMC free article] [PubMed]
  • Brand PL, van der Ent CK. The practical application and interpretation of simple lung function tests in cystic fibrosis. J R Soc Med. 1999;92 (Suppl 37):2–12. [PMC free article] [PubMed]
  • Nickerson BG, Lemen RJ, Gerdes CB, Wegmann MJ, Robertson G. Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis. 1980 Dec;122(6):859–866. [PubMed]
  • Conway SP, Watson A. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis. Thorax. 1997 Apr;52 (Suppl 2):S64–S68. [PMC free article] [PubMed]
  • Brand PL. Bronchodilators in cystic fibrosis. J R Soc Med. 2000;93 (Suppl 38):37–39. [PMC free article] [PubMed]
  • van Haren EH, Lammers JW, Festen J, van Herwaarden CL. Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis. Eur Respir J. 1992 Oct;5(9):1083–1088. [PubMed]
  • Sanchez I, Powell RE, Pasterkamp H. Wheezing and airflow obstruction during methacholine challenge in children with cystic fibrosis and in normal children. Am Rev Respir Dis. 1993 Mar;147(3):705–709. [PubMed]
  • Holzer FJ, Olinsky A, Phelan PD. Variability of airways hyper-reactivity and allergy in cystic fibrosis. Arch Dis Child. 1981 Jun;56(6):455–459. [PMC free article] [PubMed]
  • Darga LL, Eason LA, Zach DM, Polgar G. Cold air provocation of airway hyperreactivity in patients with cystic fibrosis. Pediatr Pulmonol. 1986 Mar-Apr;2(2):82–88. [PubMed]
  • Cypcar D, Lemanske RF., Jr Asthma and exercise. Clin Chest Med. 1994 Jun;15(2):351–368. [PubMed]
  • Day G, Mearns MB. Bronchial lability in cystic fibrosis. Arch Dis Child. 1973 May;48(5):355–359. [PMC free article] [PubMed]
  • Macfarlane PI, Heaf D. Changes in airflow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis. Pediatr Pulmonol. 1990;8(1):4–11. [PubMed]
  • Marchant JL, Warner JO, Bush A. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax. 1994 Oct;49(10):1002–1005. [PMC free article] [PubMed]
  • Warner JO, Kilburn SA. Cystic fibrosis and allergy. Pediatr Allergy Immunol. 1996;7(9 Suppl):67–69. [PubMed]
  • Wilmott RW. The relationship between atopy and cystic fibrosis. Clin Rev Allergy. 1991 Spring-Summer;9(1-2):29–46. [PubMed]
  • Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol. 1997 Aug;24(2):137–161. [PubMed]
  • Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000 May;161(5):1720–1745. [PubMed]
  • Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Høiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS. 2000 May;108(5):329–335. [PubMed]
  • Skov M, Poulsen LK, Koch C. Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis. Pediatr Pulmonol. 1999 Feb;27(2):74–79. [PubMed]
  • Heine RG, Button BM, Olinsky A, Phelan PD, Catto-Smith AG. Gastro-oesophageal reflux in infants under 6 months with cystic fibrosis. Arch Dis Child. 1998 Jan;78(1):44–48. [PMC free article] [PubMed]
  • Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, Strandvik B, McKenzie SG. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J. 2000 Sep;16(3):464–471. [PubMed]
  • Coren ME, Ng V, Rubens M, Rosenthal M, Bush A. The value of ultrafast computed tomography in the investigation of pediatric chest disease. Pediatr Pulmonol. 1998 Dec;26(6):389–395. [PubMed]
  • Kerem E, Reisman J, Corey M, Bentur L, Canny G, Levison H. Wheezing in infants with cystic fibrosis: clinical course, pulmonary function, and survival analysis. Pediatrics. 1992 Nov;90(5):703–706. [PubMed]
  • Cropp GJ. Effectiveness of bronchodilators in cystic fibrosis. Am J Med. 1996 Jan 29;100(1A):19S–29S. [PubMed]
  • Ziebach R, Pietsch-Breitfeld B, Bichler M, Busch A, Riethmüller J, Stern M. Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: double-blind, placebo-controlled crossover study in cystic fibrosis. Pediatr Pulmonol. 2001 Jun;31(6):431–435. [PubMed]
  • Spencer DA. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis. Thorax. 1997 Apr;52 (Suppl 2):S89–S91. [PMC free article] [PubMed]
  • Sivan Y, Arce P, Eigen H, Nickerson BG, Newth CJ. A double-blind, randomized study of sodium cromoglycate versus placebo in patients with cystic fibrosis and bronchial hyperreactivity. J Allergy Clin Immunol. 1990 Mar;85(3):649–654. [PubMed]
  • Holt S, Suder A, Weatherall M, Cheng S, Shirtcliffe P, Beasley R. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ. 2001 Aug 4;323(7307):253–256. [PMC free article] [PubMed]
  • Bargon J, Viel K, Dauletbaev N, Wiewrodt R, Buhl R. Short-term effects of regular salmeterol treatment on adult cystic fibrosis patients. Eur Respir J. 1997 Oct;10(10):2307–2311. [PubMed]
  • Hordvik NL, Sammut PH, Judy CG, Colombo JL. Effects of standard and high doses of salmeterol on lung function of hospitalized patients with cystic fibrosis. Pediatr Pulmonol. 1999 Jan;27(1):43–53. [PubMed]
  • Hordvik Nancy L, Sammut Paul H, Judy C Gerald, Colombo John L. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis. Pediatr Pulmonol. 2002 Oct;34(4):287–296. [PubMed]
  • Wanner A. Effects of methylxanthines on airway mucociliary function. Am J Med. 1985 Dec 20;79(6A):16–21. [PubMed]
  • Eber E, Oberwaldner B, Zach MS. Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. Pediatr Pulmonol. 1988;4(4):205–212. [PubMed]
  • Avital A, Sanchez I, Holbrow J, Kryger M, Chernick V. Effect of theophylline on lung function tests, sleep quality, and nighttime SaO2 in children with cystic fibrosis. Am Rev Respir Dis. 1991 Dec;144(6):1245–1249. [PubMed]
  • Greally P, Cook AJ, Sampson AP, Coleman R, Chambers S, Piper PJ, Price JF. Atopic children with cystic fibrosis have increased urinary leukotriene E4 concentrations and more severe pulmonary disease. J Allergy Clin Immunol. 1994 Jan;93(1 Pt 1):100–107. [PubMed]
  • Morice AH, Kastelik JA, Aziz I. Montelukast sodium in cystic fibrosis. Thorax. 2001 Mar;56(3):244–245. [PMC free article] [PubMed]
  • Najada Abdelhamid, Weinberger Miles. Unusual cause of chronic cough in a four-year-old cured by uvulectomy. Pediatr Pulmonol. 2002 Aug;34(2):144–146. [PubMed]
  • Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr. 1995 Apr;126(4):515–523. [PubMed]
  • Jaffe Adam, Balfour-Lynn Ian M. Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids. Paediatr Drugs. 2002;4(6):381–389. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press